Inotiv, Inc. NASDAQ:NOTV

Inotiv stock price today

$1.7
-3.05
-64.21%
Financial Health
0
1
2
3
4
5
6
7
8
9

Inotiv stock price monthly change

+111.11%
month

Inotiv stock price quarterly change

+111.11%
quarter

Inotiv stock price yearly change

+41.79%
year

Inotiv key metrics

Market Cap
126.45M
Enterprise value
466.30M
P/E
-0.33
EV/Sales
0.79
EV/EBITDA
-2.15
Price/Sales
0.19
Price/Book
0.40
PEG ratio
N/A
EPS
-2.53
Revenue
568.70M
EBITDA
28.63M
Income
-65.53M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
-58.22%
Oper. margin
-31.52%
Gross margin
46.7%
EBIT margin
-31.52%
EBITDA margin
5.04%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Inotiv stock price history

Inotiv stock forecast

Inotiv financial statements

Average Price Target
Last Year

$5

Potential upside: 194.11%

Based on estimate of 1 analysts
  • Analysts Price target

  • Financials & Ratios estimates

Inotiv, Inc. (NASDAQ:NOTV): Profit margin
Mar 2023 151.46M -9.62M -6.36%
Jun 2023 157.46M 1.84M 1.17%
Sep 2023 140.74M -9.66M -6.87%
Mar 2024 119.03M -48.07M -40.39%
Inotiv, Inc. (NASDAQ:NOTV): Earnings per share (EPS)
2024-08-08 -0.09 -0.2
Inotiv, Inc. (NASDAQ:NOTV): Debt to assets
Mar 2023 868666000 596.03M 68.61%
Jun 2023 854834000 579.50M 67.79%
Sep 2023 856530000 588.04M 68.65%
Mar 2024 815378000 608.21M 74.59%
Inotiv, Inc. (NASDAQ:NOTV): Cash Flow
Mar 2023 12.83M -8.40M -1.16M
Jun 2023 3.69M -4.49M -1.04M
Sep 2023 18.76M -7.69M -310K
Mar 2024 16.91M -4.58M -1.17M

Inotiv alternative data

Inotiv, Inc. (NASDAQ:NOTV): Employee count
Aug 2023 2,099
Sep 2023 2,099
Oct 2023 2,099
Nov 2023 2,099
Dec 2023 2,099
Jan 2024 1,955
Feb 2024 1,955
Mar 2024 1,955
Apr 2024 1,955
May 2024 1,955
Jun 2024 1,955
Jul 2024 1,955

Inotiv other data

18.96% -17.16%
of NOTV is owned by hedge funds
4.85M -3.94M
shares is hold by hedge funds

Inotiv, Inc. (NASDAQ:NOTV): Insider trades (number of shares)
Period Buy Sel
Dec 2024 117500 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
BROWN NIGEL director
Common Stock 7,500 $4.26 $31,950
Purchase
LANDMAN DAVID director
Common Stock 100,000 $4.14 $414,000
Purchase
HARRINGTON MICHAEL J director
Common Stock 10,000 $3.98 $39,820
Purchase
GARRETT MICHAEL officer: Chief Commercial Officer
Common Stock 5,000 $2.83 $14,145
Purchase
BEATTIE JOHN GREGORY officer: Chief Operating Officer
Common Stock 47,966 $3.12 $149,846
Purchase
SAGARTZ JOHN E director, officer: Chief Strate..
Common Stock 5,100 $4.91 $25,041
Purchase
BEATTIE JOHN GREGORY officer: Chief Operating Officer
Common Stock 5,000 $6.99 $34,950
Sale
PITCHFORD WILLIAM D officer: Chief Human Resources ..
Common Stock 2,123 $5.83 $12,366
Sale
NEFF R MATTHEW director
Common Stock 1,000 $6.12 $6,120
Sale
NEFF R MATTHEW director
Common Stock 500 $21.12 $10,560
Insider Compensation
Mr. Robert W. Leasure Jr. (1960) Pres, Chief Executive Officer & Director $797,400
Dr. John E. Sagartz D.V.M., DiplomateACVP, DVM, Ph.D. (1965) Chief Strategy Officer & Director
$386,900
Ms. Beth A. Taylor CPA (1965) Vice President of Fin. & Chief Financial Officer
$337,830
Monday, 23 December 2024
globenewswire.com
Tuesday, 17 December 2024
globenewswire.com
Tuesday, 3 December 2024
seekingalpha.com
globenewswire.com
Thursday, 21 November 2024
globenewswire.com
Wednesday, 20 November 2024
globenewswire.com
Monday, 16 September 2024
globenewswire.com
Wednesday, 28 August 2024
globenewswire.com
Thursday, 8 August 2024
seekingalpha.com
zacks.com
Thursday, 25 July 2024
globenewswire.com
Tuesday, 9 July 2024
investorplace.com
Monday, 1 July 2024
investorplace.com
Monday, 10 June 2024
globenewswire.com
Monday, 3 June 2024
globenewswire.com
Thursday, 23 May 2024
globenewswire.com
Thursday, 16 May 2024
businesswire.com
Wednesday, 15 May 2024
seekingalpha.com
globenewswire.com
Tuesday, 14 May 2024
InvestorPlace
GlobeNewsWire
Monday, 29 April 2024
GlobeNewsWire
Wednesday, 3 April 2024
Zacks Investment Research
Tuesday, 2 April 2024
Zacks Investment Research
Monday, 25 March 2024
Zacks Investment Research
Monday, 18 March 2024
Zacks Investment Research
Tuesday, 12 March 2024
InvestorPlace
Thursday, 7 March 2024
InvestorPlace
Zacks Investment Research
Zacks Investment Research
  • What's the price of Inotiv stock today?

    One share of Inotiv stock can currently be purchased for approximately $1.7.

  • When is Inotiv's next earnings date?

    Inotiv, Inc. is estimated to report earnings on Wednesday, 6 Aug 2025.

  • Does Inotiv pay dividends?

    No, Inotiv does not pay dividends.

  • How much money does Inotiv make?

    Inotiv has a market capitalization of 126.45M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 14.27% to 490.74M US dollars. Inotiv made a loss 108.45M US dollars in net income (profit) last year or -$0.2 on an earnings per share basis.

  • What is Inotiv's stock symbol?

    Inotiv, Inc. is traded on the NASDAQ under the ticker symbol "NOTV".

  • What is Inotiv's primary industry?

    Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.

  • How do i buy shares of Inotiv?

    Shares of Inotiv can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Inotiv's key executives?

    Inotiv's management team includes the following people:

    • Mr. Robert W. Leasure Jr. Pres, Chief Executive Officer & Director(age: 65, pay: $797,400)
    • Dr. John E. Sagartz D.V.M., DiplomateACVP, DVM, Ph.D. Chief Strategy Officer & Director(age: 60, pay: $386,900)
    • Ms. Beth A. Taylor CPA Vice President of Fin. & Chief Financial Officer(age: 60, pay: $337,830)
  • How many employees does Inotiv have?

    As Jul 2024, Inotiv employs 1,955 workers.

  • When Inotiv went public?

    Inotiv, Inc. is publicly traded company for more then 27 years since IPO on 25 Nov 1997.

  • What is Inotiv's official website?

    The official website for Inotiv is inotivco.com.

  • Where are Inotiv's headquarters?

    Inotiv is headquartered at 2701 Kent Avenue, West Lafayette, IN.

  • How can i contact Inotiv?

    Inotiv's mailing address is 2701 Kent Avenue, West Lafayette, IN and company can be reached via phone at +7 654634527.

  • What is Inotiv stock forecast & price target?

    Based on 1 Wall Street analysts` predicted price targets for Inotiv in the last 12 months, the avarage price target is $5. The average price target represents a 194.11% change from the last price of $1.7.

Inotiv company profile:

Inotiv, Inc.

inotivco.com
Exchange:

NASDAQ

Full time employees:

1,955

Industry:

Medical - Diagnostics & Research

Sector:

Healthcare

Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing services. This segment provides analytical method development and validation; drug metabolism, bioanalysis, and pharmacokinetics testing to identify and measure drug and metabolite concentrations in complex biological matrices; in vivo sampling services for the continuous monitoring of chemical changes in life; stability testing to ensure the integrity of various solutions used in nonclinical and clinical studies, and post-study analyses; non-clinical toxicology and pathology services; and climate-controlled archiving services for its customers' data and samples. The Research Products segment designs, develops, manufactures, and markets in vivo sampling systems and accessories, including disposables, training, and systems qualification; physiology monitoring tools; liquid chromatography and electrochemistry instruments platforms; analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; and in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments. The company operates in the United States, rest of North America, the Pacific Rim, Europe, and internationally. It has an agreement with BioVaxys to conduct preclinical toxicity studies for its Covid-T Immunodiagnostic program. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.

2701 Kent Avenue
West Lafayette, IN 47906-1382

CIK: 0000720154
ISIN: US45783Q1004
CUSIP: 45783Q100